Promedix, Inc. — Form D
Promedix, Inc. of PORTLAND, OR, a company, filed a Form D exempt-offering notice with the SEC on 2024-12-17. The offering totals $200K, of which $200K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-12-17
- Form: D
- Accession: 0001858277-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $200K
- Amount sold: $200K
- Investors: 1
- Date of first sale: 2024-12-02
- Revenue range: Decline to Disclose
- SEC file number: 021-532265
Issuer
- Name: Promedix, Inc.
- CIK: 0001858277
- Entity type: Corporation
- Jurisdiction: OREGON
- Incorporated: 2018
- Address: 4640 SW MACADAM AVENUE, PORTLAND, OR, 97239
- Phone: 503-961-5787
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Scott Filer | Director | PORTLAND, OR |
| MATTHEW HANSEN | Director | JOHNSTON, IA |
| David Sheridan | Director | PORTLAND, OR |
| Steven Baker | Executive Officer | Portland, OR |
| Scott Filer | Executive Officer | PORTLAND, OR |
| MATTHEW HANSEN | Executive Officer | JOHNSTON, IA |
| Robert Jenks | Executive Officer | Portland, OR |
| David Sheridan | Executive Officer | PORTLAND, OR |
| Andrew Kibler | Director | PORTLAND, OR |
| Andrew Kibler | Executive Officer | PORTLAND, OR |
Other filings by this issuer (5)
More